Leading clinicians, researchers & pharmaceutical innovators gathered to discuss the future of cancer treatment.

Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments.

The complex and costly journey of oncology drug development is reliant on robust and comprehensive clinical data. Early-stage ...

The leading professional organization for European oncologists has rolled out its first set of guidance on how its members ...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has ...

Headquartered in Riyadh, Boston Oncology Arabia is a fully integrated pharmaceutical company purpose-built for localization. The company develops, manufactures, and commercializes advanced generics, ...

Earlier this month, 21st Century Oncology, based in Fort Meyers, Fla., reported a data breach that occurred in October 2015. Now, the cancer treatment center is facing four class action lawsuits filed ...

Please provide your email address to receive an email when new articles are posted on . A viewpoint paper outlined the benefits of a well-coordinated patient-reported outcomes collection system. The ...

The "Make Health Tech Great Again" initiative, announced by President Trump, aims to modernize healthcare using AI. Tennessee Oncology is among the early adopters of ...

Fort Myers, Fla.-based 21st Century Oncology has agreed to pay HHS’ Office for Civil Rights a $2.3 million settlement to resolve issues related to a 2015 data breach that affected 2.2 million patient ...

Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio ...